Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Hualan

[Constituents and Characters]

The vaccine is approved for use in people aged 3 years old and above, especially in vulnerable people and high risk population for influenza complications, such as children, the elderly, the weak and people in influenza epidemic areas.

[Active ingredients] Hemagglutinin of prevalent strains of influenza virus in 2022-2023 northern and southern hemisphere influenza season.

an A/Victoria/2570/2019 (H1N1)pdm09-like virus;

an A/Darwin/9/2021 (H3N2)-like virus;

a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and

a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus

[Excipients] Na2HPO4, NaH2PO4, NaCl.